Achieve Life Sciences, Inc. (ACHV)
USD 4.0
(-3.85%)
USD 4.0
(-3.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -24.47 Million | -37.54 Million | -29.44 Million | -13.47 Million | -15.21 Million | -10.62 Million |
| Net Income | -29.81 Million | -42.35 Million | -33.15 Million | -14.73 Million | -16.39 Million | -12.68 Million |
| Depreciation & Amortization | 228 Thousand | 236 Thousand | 250 Thousand | 255 Thousand | 254 Thousand | 282 Thousand |
| Deferred income taxes | -4.94 Million | - | - | -2.32 Million | - | - |
| Stock-based compensation | 3.43 Million | 3.27 Million | 2.18 Million | 1.28 Million | 1.2 Million | 854 Thousand |
| Change in working capital | -778 Thousand | 99 Thousand | 1.23 Million | -285 Thousand | -273 Thousand | 928 Thousand |
| Other non-cash items | 7.39 Million | 1.19 Million | 41 Thousand | 2.32 Million | -3000.00 | 1.48 Million |
| Investing Cash Flow | -21 Thousand | - | -17 Thousand | -17 Thousand | 5.03 Million | -5.12 Million |
| Investments in PPE | -21 Thousand | - | -17 Thousand | -17 Thousand | -53 Thousand | -46 Thousand |
| Acquisitions | - | - | - | - | -5089.00 | 10 Thousand |
| Investment purchases | - | - | - | - | -25 Thousand | -5.53 Million |
| Sales/Maturities of investments | - | - | - | - | 5.11 Million | 450 Thousand |
| Other Investing Activities | - | - | - | - | 5089.00 | 10 Thousand |
| Financing Cash Flow | 15.27 Million | 19.29 Million | 36.61 Million | 32.68 Million | 17.32 Million | 19.75 Million |
| Debt repayment | - | - | -14.92 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -30 Thousand | -47.00 | - | - | - | - |
| Common Stock Issuance | 15.49 Million | 19.21 Million | 21.34 Million | 29.49 Million | 13.12 Million | 18.43 Million |
| Other Financing Activities | -220 Thousand | 83.04 Thousand | 30.19 Million | 3.18 Million | 4.19 Million | 1.32 Million |
| Accounts receivables | -6000.00 | 48 Thousand | -153 Thousand | - | -1000.00 | 2000.00 |
| Accounts payables | -1.04 Million | 819 Thousand | 509 Thousand | -527 Thousand | 715 Thousand | -69 Thousand |
| Inventory | - | -48 Thousand | 153 Thousand | - | 1000.00 | 285 Thousand |
| Other working capital | 270 Thousand | -720 Thousand | 725 Thousand | 242 Thousand | -988 Thousand | 710 Thousand |
| Cash at beginning of period | 24.77 Million | 43.07 Million | 35.9 Million | 16.71 Million | 9.56 Million | 5.55 Million |
| Cash at end of period | 15.54 Million | 24.82 Million | 43.07 Million | 35.9 Million | 16.71 Million | 9.56 Million |
| Capital Expenditure | -21 Thousand | - | -17 Thousand | -17 Thousand | -53 Thousand | -46 Thousand |
| Effect of forex changes on cash | -3000.00 | 3000.00 | -1000.00 | - | 4000.00 | - |
| Net cash flow / Change in cash | -9.22 Million | -18.25 Million | 7.16 Million | 19.18 Million | 7.14 Million | 4 Million |
| Free Cash Flow | -24.5 Million | -37.54 Million | -29.45 Million | -13.49 Million | -15.26 Million | -10.66 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.46 Million | -6.49 Million | -29.81 Million | -5.47 Million | -7.1 Million | -8.23 Million |
| Depreciation & Amortization | 57 Thousand | 57 Thousand | 228 Thousand | 57 Thousand | 58 Thousand | 55 Thousand |
| Deferred income taxes | - | - | -4.94 Million | -152 Thousand | - | - |
| Stock-based compensation | 1.45 Million | 1.28 Million | 3.43 Million | -10 Thousand | 1.17 Million | 1.19 Million |
| Change in working capital | 1.5 Million | -670 Thousand | -778 Thousand | 69 Thousand | 2000.00 | -95 Thousand |
| Other non-cash items | 1.91 Million | 2.06 Million | 7.39 Million | 1.14 Million | 738 Thousand | 413 Thousand |
| Investing Cash Flow | -46.56 Million | - | -21 Thousand | -6000.00 | -15 Thousand | - |
| Investments in PPE | - | - | -21 Thousand | -6000.00 | -15 Thousand | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -46.56 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -153 Thousand | 56.11 Million | 15.27 Million | - | - | 15.23 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -30 Thousand | -30 Thousand | - | -220.00 |
| Common Stock Issuance | -39 Thousand | 56.11 Million | 15.49 Million | 30 Thousand | - | 15.3 Million |
| Other Financing Activities | -114 Thousand | 56.11 Million | -220 Thousand | 30 Thousand | - | -69.78 Thousand |
| Accounts receivables | - | 111 Thousand | -6000.00 | -28 Thousand | 267 Thousand | -261 Thousand |
| Accounts payables | 177 Thousand | -245 Thousand | -1.04 Million | -20 Thousand | 277 Thousand | -702 Thousand |
| Inventory | - | - | - | - | -267 Thousand | 261 Thousand |
| Other working capital | 1.32 Million | -536 Thousand | 270 Thousand | 117 Thousand | -275 Thousand | 607 Thousand |
| Cash at beginning of period | 66.39 Million | 15.54 Million | 24.77 Million | 19.91 Million | 25.12 Million | 16.56 Million |
| Cash at end of period | 14.75 Million | 66.39 Million | 15.54 Million | 15.54 Million | 19.96 Million | 25.12 Million |
| Capital Expenditure | - | - | -21 Thousand | -6000.00 | -15 Thousand | - |
| Effect of forex changes on cash | - | - | -3000.00 | -3000.00 | -1000.00 | 2000.00 |
| Net cash flow / Change in cash | -51.64 Million | 50.85 Million | -9.22 Million | -4.37 Million | -5.15 Million | 8.55 Million |
| Free Cash Flow | -4.92 Million | -5.28 Million | -24.5 Million | -4.37 Million | -5.15 Million | -6.67 Million |
PAGEIND
9682
AGJ
SCFR
002335
DENORA